Loading…
Paul D. Wellstone Muscular Dystrophy Community Assistance, Research, and Education Amendments Act of 2008
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,722 other S bills in the 110th — cohort avg 42d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2008 · fourth_quarter · Health Issues
Health care issues affecting individuals with neuromuscular disease, including H.R. 5265 and S. 2618 (P.L. 110-361), the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008, and rehabilitation research programs; H.R. 3334/S. 2042, the SMA Treatment Acceleration Act; and H.R. 2295/S. 1382 (P.L. 110-373), the ALS Registry Act.
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $120,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Health Issues
Health care issues affecting individuals with neuromuscular disease, including H.R. 5265 and S. 2618 (P.L. 110-361), the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008, and rehabilitation research programs; H.R. 3334/S. 2042, the SMA Treatment Acceleration Act; and H.R. 2295/S. 1382, the ALS Registry Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Health Issues
Health care issues affecting individuals with neuromuscular disease, including H.R. 5265 and S. 2618 (P.L. 110-361), the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008, and rehabilitation research programs; H.R. 3334/S. 2042, the SMA Treatment Acceleration Act; and H.R. 2295/S. 1382 (P.L. 110-373), the ALS Registry Act.
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Health Issues
Health care issues affecting individuals with neuromuscular disease- H.R. 5265/S. 2618, Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008; H.R. 3334/S. 2042, SMA Treatment Acceleration Act; H.R. 493/S. 358 (P.L. 110-233), Genetic Information Nondiscrimination Act; H.R. 2295/S. 1382, the ALS Registry Act.
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · first_quarter · Health Issues
Health care issues affecting individuals with neuromuscular disease, including H.R. 5265/S. 2618, Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008; H.R. 3334/S. 2042, SMA Treatment Acceleration Act; H.R. 493/S. 358, Genetic Information Nondiscrimination Act; and H.R. 2295/S. 1382, the ALS Registry Act.
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Health Issues
Health care issues affecting individuals with neuromuscular disease, including H.R. 5265 and S. 2618 (P.L. 110-361), the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008, and rehabilitation research programs; H.R. 3334/S. 2042, the SMA Treatment Acceleration Act; and H.R. 2295/S. 1382, the ALS Registry Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Medical/Disease Research/Clinical Labs
S. 2618/HR 5265, "Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008"
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Health Issues
Health care issues affecting individuals with neuromuscular disease, including H.R. 5265 and S. 2618, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008, and rehabilitation research programs.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Medical/Disease Research/Clinical Labs
S. 911/HR 1553 "Conquer Childhood Cancer Act of 2007" S 2618/HR 5265 "Paul D. Wellstone Muscular Dystrophy Community Assistance, Research, and Education Amendments of 2008"
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · first_quarter · Health Issues
Health care issues affecting individuals with neuromuscular disease, including HR5265 and S2618, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2008, and rehabilitation research programs.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Democratic |
| MI |
| Charles E. Schumer | Democratic | NY |
| Christopher Dodd | Democratic | CT |
| Debbie Stabenow | Democratic | MI |
| Dianne Feinstein | Democratic | CA |
| Frank R. Lautenberg | Democratic | NJ |
| George Voinovich | Republican | OH |
| Hillary Clinton | Democratic | NY |
| John Sununu | Republican | NH |
| John Thune | Republican | SD |
| Johnny Isakson | Republican | GA |
| Joseph I. Lieberman | Independent | CT |
| Maria Cantwell | Democratic | WA |
| Norm Coleman | Republican | MN |
| Olympia J. Snowe | Republican | ME |
| Patty Murray | Democratic | WA |
| Robert Menendez | Democratic | NJ |
| Roger F. Wicker | Republican | MS |
| Saxby Chambliss | Republican | GA |
| Sherrod Brown | Democratic | OH |
| Susan M. Collins | Republican | ME |
| Thad Cochran | Republican | MS |
| Tim Johnson | Democratic | SD |
| Tom Harkin | Democratic | IA |